Emmaus Life Sciences, Inc. Quarterly report [Sections 13 or 15(d)]

Commitments and Contingencies - Additional Information (Details)			1 Months Ended		3 Months Ended	6 Months Ended
	Jul. 12, 2017 USD ($) Number	Jun. 12, 2017 USD ($)	Dec. 31, 2024 USD ($)	Dec. 31, 2024 AED (د.إ)	Jun. 30, 2025 USD ($)	Jun. 30, 2025 USD ($)
Lower court judgment amount			$ 150,000	د.إ 546,246
Appeals court award former employee amount			$ 483,500	د.إ 1,775,722
General and Administrative Expenses [Member]
Legal Settlement Expenses					$ 483,500	$ 483,500
Telcon RF Pharmaceuticals, Inc. ("Telcon") [Member] \| API Supply Agreement [Member]
Proceeds from supply agreement		$ 31,800,000
Telcon RF Pharmaceuticals, Inc. ("Telcon") [Member] \| API Supply Agreement [Member] \| PGLG [Member]
Percentage of right to supply		25.00%
Agreement term		15 years
Telcon RF Pharmaceuticals, Inc. ("Telcon") [Member] \| Revised API Agreement [Member]
Agreement term	5 years
Number of renewals \| Number	10
Cumulative purchase amount	$ 47,000,000
Annual purchase target amount	5,000,000
Target profit	$ 2,500,000